Article
Identification of PBMC-based molecular signature associational with COVID-19 disease severity
21 Apr 2021
Abstract excerpt
The longevity of COVID-19 as a global pandemic, and the devastating effects it has had on certain subsets of individuals thus far has highlighted the importance of identifying blood-based biomarkers associated with disease severity. We employed computational and transcriptome analyses of publicly available datasets from PBMCs from 126 patients with COVID-19 admitted to ICU (n = 50), COVID-19 not admitted to ICU...
Topics
Join the communities discussing this publication.